Figure 4
From: Osteoporosis Treatment: When to Discontinue and When to Re-start
Relative risk (RR) of non-vertebral fractures during FLEX study (Alendronate versus placebo) in patients ranked according with femoral neck BMD (T-score) values. In patient with persistent osteoporosis (T-score <−2.5) prosecution of treatment leads to an additional advantage also for non-vertebral fractures (10).
